FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2583897751> ?p ?o ?g. }

• W2583897751 endingPage "1104" @default.
• W2583897751 startingPage "1100" @default.
• W2583897751 abstract "Systemic lupus erythematosus (SLE) is a prototypic systemic autoimmune disease, which characterized by complex immunological abnormalities and multiple tissue and organ damages. The etiology and pathogenesis of SLE have not been entirely recognized. Genetic, environmental and viral infections and other factors might be related to the pathogenetic mechanisms of SLE. Interleukin-2 (IL-2) is a critical cytokine produced by T cells upon activation and is important for the generation of T regulatory cells and activation-induced cell death. In SLE patients, T cells display decreased capacity to produce IL-2. Impaired IL-2 expression resulted in decreased generation of regulatory T lymphocytes, and defect of activation-induced cell death. Former researches indicated that IL-2 deficiency in SLE is important for the pathogenesis and treatment of SLE. Several regulating molecules can affect the transcription of IL-2 gene and had an important role in the pathogenesis of SLE. These molecules include cyclic AMP-responsive element modulator (CREM), protein phosphatase 2A (PP2A), E-74 like factor 1 (Elf-1), B lymphocyte induced maturation protein-1 (Blimp-1) and interferon regulator factor 5 (IRF-5). CREM is a transcriptional inhibitor that can repress the transcription of the IL-2 gene by binding to the promoter of the IL-2 gene. PP2A is a Ser/Thr phosphatase that expressed in eukaryotic cells ubiquitously, it represents a negative regulator of the IL-2 gene promoter activity. Elf-1 belongs to the Ets family of transcription factors and can promote the expression of IL-2. Blimp-1 is a crucial transcription factors for regulating B lymphocyte terminal differentiation, an important function of Blimp-1 in T cells is to repress IL-2 gene transcription directly. Interferon regulatory factors (IRFs) are distinctive transcriptional regulators of type I interferons (IFNs) and IFN inducible genes, IRF-5 is a member of the IRFs family. IRF-5 is found to be increased in SLE and can regulate the production of IL-2 negatively. PP2A can inhibit the synthesis of IL-2 in two ways: on the one hand, activating the IL-2 transcription inhibitory factor CREMα, on the other hand, inhibiting IL-2 stimulating transcription factor Elf-1. While IRF-5 can activate the IL-2 transcription negative regulator Blimp-1 as to inhibit IL-2 expression. These molecules participate in the regulation of IL-2 through different pathways. This paper reviews the current knowledge of IL-2 signaling pathway regulating molecules in SLE." @default.
• W2583897751 created "2017-02-10" @default.
• W2583897751 creator A5048114554 @default.
• W2583897751 creator A5073166506 @default.
• W2583897751 creator A5078514802 @default.
• W2583897751 date "2016-12-18" @default.
• W2583897751 modified "2023-09-23" @default.
• W2583897751 title "[Interleukin-2 signaling pathway regulating molecules in systemic lupus erythematosus]." @default.
• W2583897751 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27987522" @default.
• W2583897751 hasPublicationYear "2016" @default.
• W2583897751 type Work @default.
• W2583897751 sameAs 2583897751 @default.
• W2583897751 citedByCount "1" @default.
• W2583897751 countsByYear W25838977512018 @default.
• W2583897751 crossrefType "journal-article" @default.
• W2583897751 hasAuthorship W2583897751A5048114554 @default.
• W2583897751 hasAuthorship W2583897751A5073166506 @default.
• W2583897751 hasAuthorship W2583897751A5078514802 @default.
• W2583897751 hasConcept C104317684 @default.
• W2583897751 hasConcept C11960822 @default.
• W2583897751 hasConcept C165864922 @default.
• W2583897751 hasConcept C178666793 @default.
• W2583897751 hasConcept C203014093 @default.
• W2583897751 hasConcept C2778690821 @default.
• W2583897751 hasConcept C2780942790 @default.
• W2583897751 hasConcept C389152 @default.
• W2583897751 hasConcept C54355233 @default.
• W2583897751 hasConcept C86339819 @default.
• W2583897751 hasConcept C86803240 @default.
• W2583897751 hasConcept C95444343 @default.
• W2583897751 hasConceptScore W2583897751C104317684 @default.
• W2583897751 hasConceptScore W2583897751C11960822 @default.
• W2583897751 hasConceptScore W2583897751C165864922 @default.
• W2583897751 hasConceptScore W2583897751C178666793 @default.
• W2583897751 hasConceptScore W2583897751C203014093 @default.
• W2583897751 hasConceptScore W2583897751C2778690821 @default.
• W2583897751 hasConceptScore W2583897751C2780942790 @default.
• W2583897751 hasConceptScore W2583897751C389152 @default.
• W2583897751 hasConceptScore W2583897751C54355233 @default.
• W2583897751 hasConceptScore W2583897751C86339819 @default.
• W2583897751 hasConceptScore W2583897751C86803240 @default.
• W2583897751 hasConceptScore W2583897751C95444343 @default.
• W2583897751 hasIssue "6" @default.
• W2583897751 hasLocation W25838977511 @default.
• W2583897751 hasOpenAccess W2583897751 @default.
• W2583897751 hasPrimaryLocation W25838977511 @default.
• W2583897751 hasRelatedWork W1980107542 @default.
• W2583897751 hasRelatedWork W2005320857 @default.
• W2583897751 hasRelatedWork W2027383039 @default.
• W2583897751 hasRelatedWork W2056067227 @default.
• W2583897751 hasRelatedWork W2146526187 @default.
• W2583897751 hasRelatedWork W2155702314 @default.
• W2583897751 hasRelatedWork W2157086170 @default.
• W2583897751 hasRelatedWork W2318332039 @default.
• W2583897751 hasRelatedWork W2395860629 @default.
• W2583897751 hasRelatedWork W139682501 @default.
• W2583897751 hasVolume "48" @default.
• W2583897751 isParatext "false" @default.
• W2583897751 isRetracted "false" @default.
• W2583897751 magId "2583897751" @default.
• W2583897751 workType "article" @default.